- Home
- FGI vs BDRX Comparison
FGI vs BDRX Comparison
Compare FGI & BDRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FGI
- BDRX
- Stock Information
- Founded
- FGI 1987
- BDRX 2000
- Country
- FGI United States
- BDRX United Kingdom
- Employees
- FGI N/A
- BDRX N/A
- Industry
- FGI Industrial Specialties
- BDRX Biotechnology: Pharmaceutical Preparations
- Sector
- FGI Industrials
- BDRX Health Care
- Exchange
- FGI Nasdaq
- BDRX Nasdaq
- Market Cap
- FGI 6.8M
- BDRX 5.8M
- IPO Year
- FGI 2022
- BDRX N/A
- Fundamental
- Price
- FGI $0.76
- BDRX $0.88
- Analyst Decision
- FGI
- BDRX
- Analyst Count
- FGI 0
- BDRX 0
- Target Price
- FGI N/A
- BDRX N/A
- AVG Volume (30 Days)
- FGI 209.6K
- BDRX 1.3M
- Earning Date
- FGI 08-06-2025
- BDRX 04-11-2025
- Dividend Yield
- FGI N/A
- BDRX N/A
- EPS Growth
- FGI N/A
- BDRX N/A
- EPS
- FGI N/A
- BDRX N/A
- Revenue
- FGI $134,277,102.00
- BDRX N/A
- Revenue This Year
- FGI $7.72
- BDRX N/A
- Revenue Next Year
- FGI $6.94
- BDRX N/A
- P/E Ratio
- FGI N/A
- BDRX N/A
- Revenue Growth
- FGI 11.13
- BDRX N/A
- 52 Week Low
- FGI $0.46
- BDRX $0.78
- 52 Week High
- FGI $1.10
- BDRX $19.75
- Technical
- Relative Strength Index (RSI)
- FGI 51.23
- BDRX 44.57
- Support Level
- FGI $0.77
- BDRX $0.84
- Resistance Level
- FGI $0.86
- BDRX $0.95
- Average True Range (ATR)
- FGI 0.12
- BDRX 0.09
- MACD
- FGI -0.00
- BDRX 0.01
- Stochastic Oscillator
- FGI 25.55
- BDRX 15.09
About FGI FGI Industries Ltd.
FGI Industries Ltd is a supplier of kitchen and bath products. The company is business to business supplier of bath and kitchen products to large retail, wholesale, commercial, and specialty channel customers around the globe. The company offers products that fall into four categories: Sanitaryware, Bath Furniture, Shower Systems and Other. The company generates the majority of its revenue from the sale of Sanitaryware products. Geographically, the company generates the majority of its revenue from the United States, followed by Canada and Europe.
About BDRX Biodexa Pharmaceuticals plc
Biodexa Pharmaceuticals PLC is a clinical-stage biopharmaceutical company focused on developing a pipeline of products to treat diseases that have unmet medical needs. These include familial adenomatous polyposis (FAP), non-muscle invasive bladder cancer (NMIBC), type 1 diabetes (T1D), and rare or orphan brain cancers.